LABS

Tetra Pharm Technologies introduces pain relieving drug in the United Kingdom

Retrieved on: 
Tuesday, March 19, 2024

COPENHAGEN, Denmark, March 19, 2024 /PRNewswire/ -- Following last year's successful launch of XATEPA® in Germany, the cannabinoid-based product will now become available to patients in the United Kingdom during Q2 2024.

Key Points: 
  • The Danish biopharmaceutical company, Tetra Pharm Technologies, is proud to announce the launch of its pain-relieving prescription drug, XATEPA®, in the United Kingdom.
  • XATEPA® is a carefully formulated drug designed to provide effective relief from chronic pain as well as discomfort arising from MS spasms and nausea.
  • For the distribution of XATEPA® in the United Kingdom, Tetra Pharm Technologies has entered a strategic agreement with 4C LABS Ltd. who cooperate with a wide network of clinics, doctors, and patient organizations.
  • "4C LABS are excited to be the exclusive distributors in the United Kingdom for the suite of Tetra Pharm Technologies' cannabinoid-based prescription drugs.

Tetra Pharm Technologies introduces pain relieving drug in the United Kingdom

Retrieved on: 
Tuesday, March 19, 2024

COPENHAGEN, Denmark, March 19, 2024 /PRNewswire/ -- Following last year's successful launch of XATEPA® in Germany, the cannabinoid-based product will now become available to patients in the United Kingdom during Q2 2024.

Key Points: 
  • The Danish biopharmaceutical company, Tetra Pharm Technologies, is proud to announce the launch of its pain-relieving prescription drug, XATEPA®, in the United Kingdom.
  • XATEPA® is a carefully formulated drug designed to provide effective relief from chronic pain as well as discomfort arising from MS spasms and nausea.
  • For the distribution of XATEPA® in the United Kingdom, Tetra Pharm Technologies has entered a strategic agreement with 4C LABS Ltd. who cooperate with a wide network of clinics, doctors, and patient organizations.
  • "4C LABS are excited to be the exclusive distributors in the United Kingdom for the suite of Tetra Pharm Technologies' cannabinoid-based prescription drugs.

Village Farms International Announces Launch of Top-Selling Cannabis Brands in the UK

Retrieved on: 
Wednesday, January 3, 2024

VANCOUVER, British Columbia, Jan. 03, 2024 (GLOBE NEWSWIRE) --  Village Farms International, Inc. (“Village Farms” or the “Company”) (NASDAQ: VFF) today announced the first shipment and launch of two leading cannabis brands in the United Kingdom (UK). The Company’s Pure Sunfarms and The Original Fraser Valley Weed Co. (“Fraser Valley”) brands will be distributed by 4C LABS, a leading UK medical cannabis company focused on providing patients with world class medical cannabis products. The launch includes three of Village Farms’ most popular strains in Canada: Pink Kush, Jet Fuel Gelato and D. Burger. Pure Sunfarms’ Pink Kush is a long-standing favorite among Canadian consumers, consistently holding the top-selling spot in dried flower nationally over the past two years1. Pure Sunfarms’ Jet Fuel Gelato rapidly became a consumer favorite in Ontario, Canada’s largest provincial market. And Fraser Valley’s D. Burger is the third best-selling dried flower strain in Ontario2.

Key Points: 
  • VANCOUVER, British Columbia, Jan. 03, 2024 (GLOBE NEWSWIRE) -- Village Farms International, Inc. (“Village Farms” or the “Company”) (NASDAQ: VFF) today announced the first shipment and launch of two leading cannabis brands in the United Kingdom (UK).
  • The launch includes three of Village Farms’ most popular strains in Canada: Pink Kush, Jet Fuel Gelato and D. Burger.
  • “This launch of our leading BC-grown cannabis brands is a game-changer for patients in the UK, the third most populated country in Europe,” said Michael DeGiglio, Chief Executive Office, Village Farms.
  • Village Farms is known to be best in the world at delivering such quality, with stable supply, and we are confident these brands will resonate with UK consumers immediately upon launch and support 4C LABS in our goal to build a dominant position in the UK medical cannabis market.”

BZAM Ltd. & 4C LABS conclude strategic distribution agreement for the UK market

Retrieved on: 
Tuesday, October 31, 2023

The Company is shipping its first 150kg of TGOD's top strains to 4C LABS for onward distribution to 4C LABS pharmacy clients in the United Kingdom (UK).

Key Points: 
  • The Company is shipping its first 150kg of TGOD's top strains to 4C LABS for onward distribution to 4C LABS pharmacy clients in the United Kingdom (UK).
  • Pursuant to the agreement, signed on April 29, 2023, the Company will supply 4C LABS with approximately 600KG of flower annually for the next two years.
  • 4C LABS believes that there is strong demand for quality, organic Canadian cannabis products in the UK's burgeoning medical cannabis market.
  • The team at 4C LABS expects the market to expand over the next five years, mirroring previously legalized medical markets elsewhere, and expects this new agreement will enable them to establish a dominant position in the UK medical cannabis market.

Decibel Expands Global Footprint with Agreement to Supply Medical Cannabis to 4C LABS for Distribution in the United Kingdom

Retrieved on: 
Wednesday, August 30, 2023

Decibel to supply 4C LABS with Qwest branded, craft-quality Medical Cannabis for distribution to UK medical cannabis patients

Key Points: 
  • Decibel to supply 4C LABS with Qwest branded, craft-quality Medical Cannabis for distribution to UK medical cannabis patients
    "We are excited to partner with 4C LABS, a leading organization in the growing medical cannabis industry in the UK, that echoes Decibel's commitment to quality and patient care.
  • "Decibel's success with Qwest flower products in Canada and in Israel's medical market reinforces the demand for premium cannabis products and the reputation we have built to service that demand."
  • "4C LABS is building a patient focused best-in-class product line for the UK & Channel Islands, the Qwest craft flower line strengthens the top end of the 4C LABS product offerings.
  • Decibel's innovative craft quality Qwest flower products will fill an empty segment in the UK market and bring a world class BC Cannabis product to UK patients," said Greg Dobbin, CEO 4C LABS.

Organigram to Enter the United Kingdom with Agreement to Supply Medical Cannabis to 4C LABS

Retrieved on: 
Tuesday, August 15, 2023

Key Points: 
  • View the full release here: https://www.businesswire.com/news/home/20230815619279/en/
    Organigram to Enter the United Kingdom with Agreement to Supply Medical Cannabis to 4C LABS (Photo: Business Wire)
    Under the terms of the Agreement, the Company expects to supply approximately 600 kilograms of high-quality, indoor-grown dried flower product to 4C LABS within the first year of the Agreement, and grant 4C LABS strain exclusivity within the geographical boundaries of the United Kingdom & Channel Islands for as long as minimum purchase commitments are satisfied.
  • “Medical Cannabis has been legal in the UK since 2018.
  • “We are excited to partner with 4C LABS to increase access to Medical Cannabis for UK Medical Cannabis patients."
  • “4C LABS is focused on delivering a value proposition to UK patients, 4C LABS provides top quality products, industry leading pricing, best in class customer service and a robust supply chain," says Greg Dobbin, Chief Executive Officer of 4C LABS.

LABS Group Distributes Dividends to Early Investors of Kunang Kunang Tent Resort

Retrieved on: 
Tuesday, July 25, 2023

Singapore, July 25, 2023 - LABS Group , the frontrunner in blockchain-based real estate investment, is delighted to announce the successful distribution of dividends to early investors of the Kunang Kunang Tent Resort project based in Indonesia.

Key Points: 
  • Singapore, July 25, 2023 - LABS Group , the frontrunner in blockchain-based real estate investment, is delighted to announce the successful distribution of dividends to early investors of the Kunang Kunang Tent Resort project based in Indonesia.
  • The Kunang Kunang Tent Resort, nestled in a coveted location famed for its natural beauty, has become a point of interest for avant-garde investors seeking unique real estate market opportunities.
  • Early investors of the Kunang Kunang Tent Resort have been vital to supporting this revolutionary project from its genesis.
  • "Our early investors have been instrumental in turning the vision of the Kunang Kunang Tent Resort into a reality," said Bernard Lau, CEO of LABS Group.

UltiMaker Launches the Method XL 3D Printer to Deliver Unrivaled Accuracy and Precision for Engineering Applications

Retrieved on: 
Tuesday, May 23, 2023

BROOKLYN, N.Y. and UTRECHT, Netherlands, May 23, 2023 /PRNewswire/ -- UltiMaker, a global leader in 3D printing, today announces the launch of Method XL, the ultimate 3D printing solution for engineering applications, offering precision printing with industrial-grade materials without compromising on part size. The UltiMaker® Method™ XL 3D printer is designed to deliver the accuracy and performance of industrial production alongside the flexibility and affordability of a desktop 3D printer.

Key Points: 
  • The UltiMaker® Method™ XL 3D printer is designed to deliver the accuracy and performance of industrial production alongside the flexibility and affordability of a desktop 3D printer.
  • Method XL is engineered to create large, complex parts that are durable using industrial-grade materials like ABS-R and ABS Carbon Fiber.
  • "With Method XL, we believe we are bringing customers the best 3D printing solution in the market for engineering applications.
  • The printer comes equipped with a HEPA filter and an activated carbon filter for safer 3D printing indoors.

UltiMaker Launches the Method XL 3D Printer to Deliver Unrivaled Accuracy and Precision for Engineering Applications

Retrieved on: 
Tuesday, May 23, 2023

BROOKLYN, N.Y. and UTRECHT, Netherlands, May 23, 2023 /PRNewswire/ -- UltiMaker, a global leader in 3D printing, today announces the launch of Method XL, the ultimate 3D printing solution for engineering applications, offering precision printing with industrial-grade materials without compromising on part size. The UltiMaker® Method™ XL 3D printer is designed to deliver the accuracy and performance of industrial production alongside the flexibility and affordability of a desktop 3D printer.

Key Points: 
  • The UltiMaker® Method™ XL 3D printer is designed to deliver the accuracy and performance of industrial production alongside the flexibility and affordability of a desktop 3D printer.
  • Method XL is engineered to create large, complex parts that are durable using industrial-grade materials like ABS-R and ABS Carbon Fiber.
  • "With Method XL, we believe we are bringing customers the best 3D printing solution in the market for engineering applications.
  • The printer comes equipped with a HEPA filter and an activated carbon filter for safer 3D printing indoors.

BZAM Ltd. & 4C LABS conclude strategic distribution agreement for the UK market

Retrieved on: 
Tuesday, May 23, 2023

VANCOUVER, BC, TORONTO and LONDON, May 23, 2023 /PRNewswire/ - BZAM Ltd. (the "Company" or "BZAM") (CSE: BZAM) (US-OTC: BZAMF), is pleased to announce that its subsidiary, The Green Organic Dutchman Ltd. (collectively the "Company") has entered into a strategic distribution agreement with 4C LABS Ltd. ("4C LABS"), a London, UK based import & distribution company focused on the medical cannabis space.

Key Points: 
  • VANCOUVER, BC, TORONTO and LONDON, May 23, 2023 /PRNewswire/ - BZAM Ltd. (the "Company" or "BZAM") (CSE: BZAM) (US-OTC: BZAMF), is pleased to announce that its subsidiary, The Green Organic Dutchman Ltd. (collectively the "Company") has entered into a strategic distribution agreement with 4C LABS Ltd. ("4C LABS"), a London, UK based import & distribution company focused on the medical cannabis space.
  • The Company and 4C LABS expect to commercialize medical cannabis products under The Green Organic Dutchman brand in the UK beginning in Q4 2023.
  • 4C LABS believes that there is strong demand for quality, organic Canadian cannabis products in the UK's burgeoning medical cannabis market.
  • Matt Milich, BZAM's CEO, stated: "We are proud to announce this agreement with 4C LABS to bring our exceptional product to the UK market.